SCHEMBL26291464

SCHEMBL26291464

C=CC(=O)OCOc1ccc2cc(-c3ccccc3)oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 1/20 0.47
▸ RAB9A P51151 5/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ KDM4E B2RXH2 6/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ GLA P06280 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ MAPT P10636 2/20 0.44
▸ THRB P10828 1/20 0.44
▸ SLC16A3 O15427 2/20 0.43
▸ S1PR1 P21453 1/20 0.41
▸ S1PR3 Q99500 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20473379 0.89 THRB (0.49) THRBS1PR1S1PR3
SCHEMBL21735226 0.86 RAB9A (0.43) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL26291461 0.84 RAB9A (0.40) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL20473131 0.84 THRB (0.44) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL21735096 0.84 RAB9A (0.40) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL26291480 0.83 PTPN1 (0.47) RAB9ANPC1KDM4EALDH1A1HPGD
SCHEMBL21734947 0.83 THRB (0.44) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL21735213 0.83 NPC1 (0.39) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL22630038 0.82 RAB9A (0.41) HDAC6RAB9ANPC1KDM4EALDH1A1
SCHEMBL21735560 0.82 THRB (0.43) HDAC6RAB9ANPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D HDAC6 2371/4885RAB9A 1119/4885NPC1 2727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback